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pituitary Metastasis: Lung Cancer Presenting as Bitemporal 
hemianopsia with Diabetes Insipidus and Anterior Pituitary Deficiency 
4. Keith Cryar, MD,* Jay Morgan, MD,t Jack P. Rock, MD,^  and Max Wisgerhof, MD* 
I 
Symptoms and signs of pituitary disease are rarely the first manifestations of malignancy originating 
in another organ. We present a case which exemplifies the key points that suggest a diagnosis of 
metastatic pituitary disease. Our patient's diagnosis wds adenocarcinoma ofthe lung with a 
metastasis to the intrasellar and suprasellar regions, which caused diabetes insipidus, anterior 
pituitary deficiency, arui visual field defects. The metastasis had a dumbbell appearance and extended 
from the sella turcica into the suprasellar region. Diabetes insipidus was the initial clinical 
manifestation of lung cancer in this patient. A metastasis to the pituitary should be suspected if 
diabetes insipidus is the initial manifestation ofan intrasellar mass. (Henry Ford Hosp Med J 
1987:35:185-7) 
Metastatic pituitary disease is rarely recognized clinically. Even when clinical suspicion is high, as in patients known 
to have cancer, tumor metastatic to the pituitary is usually recog-
nized only at autopsy (1,2). Nevertheless, symptoms or signs of 
pituitary disease can be the first manifestation of malignancy 
originating in another organ (3-5). Such a case is presented, 
which exemplifies the key points that suggest a diagnosis of met-
astatic disease in the pituitary. 
Case Report 
A 62-year-old man presented with a chief complaint of peripheral 
vision loss occurring over several days. He had had several weeks of 
mild, intermittent diplopia, but he did not seek medical care until the 
loss of peripheral vision began to interfere with his golf game. 
On questioning, he revealed that six months ago his usual nocturia 
had increased to six to eight times per night with daytime polyuria and 
polydipsia of about two gallons of liquids per day. He had lost 20 
pounds over the last six months, and for four months he had experi-
enced fatigue, constipation, intolerance of the cold, dryness ofthe skin 
and hair, altered sense of taste, anosmia, and impaired mentation. Left-
sided occipital headaches enduring several hours had been present 
mornings for the last two months. A two-year history of decreased 
libido had recently progressed to complete loss of libido with hot 
Hushes and impotence. 
His history was remarkable for a 35 pack/year habit of cigarette 
smoking. He had stopped smoking five years ago when chronic 
obstructive pulmonary disease with bronchospasm was diagnosed. One 
year ago, daily prednisone treatment was added to the other treatments 
forthis disease. 
Physical examination showed him to be well developed, well nour-
'^ lied, and in no acute distress. His vital signs were normal. His hair was 
""e. dry, and normally distributed. There was bilateral papilledema and 
•I'plopia on upward gaze. Goldmann visual field testing showed bilat-
temporal field defects (right greater than left). His lung fields were 
clear with a prolonged expiratory phase, and no abnormal cardiac or 
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abdominal signs were present. Lymphadenopathy was not present. The 
relaxation phase was delayed in the deep tendon reflexes, and the testi-
cles were soft. 
His complete blood count and automated chemistry profile were nor-
mal , except for a semm sodium of 145 mmol/L. The urine specific grav-
ity was 1.004, and the urine osmolality was 220 mosm/kg. The serum 
thyroxine was 4.9 p-g/dL, thyroid-stimulating hormone 1.2 |jirU/mL, 
testosterone < 20 ng/dL, luteinizing hormone < 2.5 p,rU/mL, and pro-
lactin 19 ng/mL. Cortisol was not measured because of the chronic 
treatment with prednisone. Chest roentgenogram revealed a 4.0 cm 
opacity in the superior segment of the lingula, enlargement of the root 
of the left lung, and thickening of the soft tissues in the right para-
tracheal region. These findings suggested the presence of lung cancer in 
the lingula with metastases to the lung root and the right paratracheal 
area. Cranial computed tomography showed an enlarged sella turcica 
containing a dumbbell-shaped, enhancing mass extending into the 
suprasellar region to the foramen of Monro and compressing the optic 
chiasm (Figure). 
A presumptive diagnosis was made of primary lung cancer with me-
tastasis to the sellar and suprasellar regions causing diabetes insipidus, 
hypothalamic dysfunction, anterior pituitary deficiency, and visual 
field defects. He was treated with replacement therapy of DDAVP, 
thyroxine, and testosterone. Prednisone was continued. Bronchoscopic 
biopsy was positive for well-differentiated adenocarcinoma ofthe 
lung. He underwent frontal craniotomy to relieve the visual field de-
fects, and histological examination of the pituitary mass revealed ade-
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Figure—Cranial computed tomography showing a dumbbell-
shaped, enhancing mass (arrows) in the sella extending into the 
suprasellar region. 
nocarcinoma, similar to the lung neoplasm. Postoperatively, Goldmann 
visual fields showed resolution of the temporal field defects. He was 
subsequentiy treated with chemotherapy and whole brain radiation. 
Discussion 
Interest in this case stems from the presentation of a symp-
tomatic sellar mass as the initial manifestation of a previously 
unrecognized lung cancer The autopsy incidence of metastatic 
pituitary disease varies depending on the series cited. Reports 
from unselected autopsies document as little as 0.14% to 1.0% 
involvement, while autopsy series on cancer patients have dem-
onstrated up to a 28% incidence (1,2). Cancer of almost every 
type has been described as a source of metastases to the pituitary 
(6). Among the solid tumors, breast and lung cancer predomi-
nate. Metastases from lung cancer account for up to 60% of 
pituitary metastases among men (1,4,6), and breast cancer me-
tastases account for up to 70% of pituitary metastases among 
women (4). 
There is a predilection for pituitary metastases to occur in the 
neurohypophysis (1,3,5,7). A review of the literature by Max et 
al (3) revealed that of 178 reported cases of pituitary metastases, 
the neurohypophysis was involved alone in 52% and the ade-
nohypophysis was involved alone in only 21%. The reason for 
this discrepancy in presentation is thought to be inherent in the 
blood supply to the pituitary gland. Arterial blood is supplied 
directly to the neurohypophysis by the inferior hypophyseal 
arteries. The blood supply to the anterior pituitary is predomi-
nantly postcapillary blood from the hypothalamus via the long 
portal veins. This would suggest that the higher frequency of 
metastases to the posterior pituitary than to the anterior pituitary 
is due to the predominantly portal (postcapillary) type of blood 
supply to the anterior pituitary. Supporting evidence for this hy-
pothesis is provided by Goldman and Sapirstein's studies (8) in 
which radioactive microspheres injected into the carotid arteries 
of rats localized in the neurohypophysis and hypothalamus, and 
not in the adenohypophysis. 
The anterior pituitary is involved in up to 67% of the cases of 
pituitary metastases evaluated at autopsy, but anterior pituitary 
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dysfunction is rare (1,3,4). In reviewing 28 previously reported 
cases of symptomatic pituitary metastases in which sufficiem 
endocrinological data were available. Max et al (3) found that 
only three of the patients had anterior pituitary deficiency. In % 
of 88 cases of pituitary metastases, Teears and Silverman (4) 
found discrete anterior pituitary infarcts which were postulated 
to have occurred secondary to neurohypophyseal involvement 
with metastatic disease compromising the blood supply to the 
adenohypophysis. None of the infarcts resulted in anterior pituj. 
tary dysfunction. The low frequency of anterior pituitary dys-
function in pituitary metastasis may be best explained by the fact 
that a large portion of the anterior pituitary must be destroyed 
before clinical hypopituitarism is evident (1,9,10). 
The majority of cases of pituitary metastases recognized ante-
mortem have diabetes insipidus (3). The presence of diabetes 
insipidus early in the course of metastasis to the pituitary is illus-
trated in Kimmel and O'Neill's series (6). In 11 of 25 patients, 
diabetes insipidus as a complication of metastatic disease was 
the initial symptom of the malignancy. That diabetes insipidus is 
a clue to the presence of metastasis is also shown by the same 
report. In 100 consecutive cases of diabetes insipidus at Mayo 
Clinic, 14% were secondary to metastatic disease, 27% were 
secondary to trauma, and 25% were idiopathic (6). Most cases 
of pituitary metastases are asymptomatic, however Teears and 
Silverman (4) found that only 7% of 88 patients with pituitary 
metastases had diabetes insipidus. 
Because of the origin of antidiuretic hormone in the supra-
optic and paraventricular nuclei, hypothalamic dysfunction 
must be present in patients with persistent diabetes insipidus. In 
our patient, symptoms of impaired smell, taste, libido, and 
mentation were present in addition to diabetes insipidus. These 
symptoms indicate effects of the metastasis beyond its immedi-
ate sellar-suprasellar location. 
The most common cause of an intrasellar mass is a pituitary 
adenoma in patients with or without malignancy (3). Adenomas 
usually manifest with anterior pituitary dysfunction or visual 
field defects (3). Diabetes insipidus is typically a late finding 
(11). In metastatic disease to the pituitary, diabetes insipidus is 
usually the first noted abnormality of pituitary function with an-
terior pituitary deficiency occurring after the onset of diabetes 
insipidus (3,4), as in the present case. 
Treatment of an intrasellar mass in cancer patients depends 
upon the clinical picture. If it is that of a benign mass and 
survival with the cancer is expected to be six or more months, 
treatment should be the same as for patients without cancer. If. 
however, the clinical picture is that of a pituitary metastasis, 
treatment should be irradiation to the pituitary. Surgical intet' 
vention would be indicated if the discovery of metastasis wou' 
influence therapy of the primary cancer or if surgery would I* 
sight-saving. 
If surgical intervention is indicated, the transfrontalorth' 
transsphenoidal route may be used for tissue diagnosis and op" 
apparatus decompression. Although in our patient the dumD"^  
shape of the lesion might not have lent itself to thorough 
compression through the sphenoid, either method can be 
tive in decompressing the optic apparatus. The transspheno' 
route is safer, easier for the patient to tolerate, and has the tc 
oretical advantage of not opening the intracranial space to tum 
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In conclusion, pituitary metastasis is a frequent complication 
of malignancy but is infrequently recognized antemortem. 
^en clinically evident, it will likely present as diabetes in-
sipidus. Symptoms or signs of anterior pituitary deficiency and 
[,ypothalamic dysfunction may subsequently occur. Patients 
0ay present with pituitary metastasis as the initial manifestation 
of malignancy. An intrasellar mass which presents with diabetes 
Insipidus or anterior pituitary deficiency preceded by diabetes 
insipidus should suggest the presence of a metastasis to the 
pituitary. Appropriate treatment of a pituitary metastasis is usu-
ally irradiation. Surgical treatment is indicated if definite dem-
gnstration of metastatic disease would affect therapy of the 
primary tumor or if surgery would be sight-saving. 
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